Guangming Xiao

机构：Guangdong Provincial People's Hospital, Guangzhou Eighth People's Hospital

发表论文 20 篇 · 总被引 809 次 · h-index 11

代表论文

• Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial (2020 · Med · 被引 304)
• An exploratory randomized controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI) (2020 · medRxiv · 被引 143)
• Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia (2020 · JAMA Internal Medicine · 被引 82)
• Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B (2022 · Journal of Hepatology · 被引 72)
• Clinical Characteristics of Patients Infected With the Novel 2019 Coronavirus (SARS-Cov-2) in Guangzhou, China (2020 · Open Forum Infectious Diseases · 被引 56)
• Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial (2014 · Trials · 被引 36)